Ecolab Inc. reported better-than-expected earnings and revenues for the second quarter of 2026, with organic sales of $4.28 billion, up 5% from $4.09 billion a year earlier, and Digital sales rising 27% year over year to $121 million. Reported volume increased 1% despite a nearly 1% headwind from customer operations disrupted by the Middle East conflict, while pricing improved to 4% on the initial benefits of the company's energy surcharge implementation, which management expects to reach 5%-6% in the second half. The water, hygiene and infection prevention solutions provider, which carries a Zacks Rank #3 (Hold) and a market capitalization of $77.9 billion, said its Global High-Tech business delivered more than 20% organic sales growth in the first quarter of 2026, and that the Ovivo Electronics acquisition, together with the pending CoolIT Systems acquisition, is expected to create a roughly $1.5 billion Global High-Tech platform. Ecolab Digital has surpassed $400 million in annualized revenues and addresses a $13 billion market opportunity, including nearly $3 billion within the existing customer base. The Zacks Consensus Estimate for Ecolab's 2026 earnings has remained stable at $8.19 per share over the past 30 days, while third-quarter 2026 revenues are pegged at $4.68 billion, indicating a 12.3% improvement from the year-ago quarter.
Veracyte Inc
West Pharmaceutical Services IncEcolab IncEcolab beat Q2 2026 earnings and revenue estimates with organic sales up 5% to $4.28 billion.
OK Rusal MKPAO
Globus Medical